291 related articles for article (PubMed ID: 33794208)
21. HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study.
Matsumoto K; Maeda H; Oki A; Takatsuka N; Yasugi T; Furuta R; Hirata R; Mitsuhashi A; Fujii T; Hirai Y; Iwasaka T; Yaegashi N; Watanabe Y; Nagai Y; Kitagawa T; Yoshikawa H;
Int J Gynecol Cancer; 2012 Mar; 22(3):471-8. PubMed ID: 22391763
[TBL] [Abstract][Full Text] [Related]
22. Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer.
de Araujo Souza PS; Maciag PC; Ribeiro KB; Petzl-Erler ML; Franco EL; Villa LL
BMC Cancer; 2008 Aug; 8():246. PubMed ID: 18721466
[TBL] [Abstract][Full Text] [Related]
23. Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.
Castro FA; Ivansson EL; Schmitt M; Juko-Pecirep I; Kjellberg L; Hildesheim A; Gyllensten UB; Pawlita M
Int J Cancer; 2012 Jan; 130(2):349-55. PubMed ID: 21387292
[TBL] [Abstract][Full Text] [Related]
24. A variant upstream of HLA-DRB1 and multiple variants in MICA influence susceptibility to cervical cancer in a Swedish population.
Chen D; Hammer J; Lindquist D; Idahl A; Gyllensten U
Cancer Med; 2014 Feb; 3(1):190-8. PubMed ID: 24403192
[TBL] [Abstract][Full Text] [Related]
25. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
26. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
[TBL] [Abstract][Full Text] [Related]
27. Association of DRB1 and DQB1 HLA class II polymorphisms in high-grade and neoplastic cervical lesions of women from Argentina.
Eiguchi K; Tatti S; Alonio LV; González JV; Leirós GJ; Fleider L; Vighi S; Padros K; Raimondi E; Teyssié A; Picconi MA
J Low Genit Tract Dis; 2008 Oct; 12(4):262-8. PubMed ID: 18820539
[TBL] [Abstract][Full Text] [Related]
28. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma.
Apple RJ; Becker TM; Wheeler CM; Erlich HA
J Natl Cancer Inst; 1995 Mar; 87(6):427-36. PubMed ID: 7861462
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion.
Tavares MC; de Lima Júnior SF; Coelho AV; Marques TR; de Araújo DH; Heráclio Sde A; Amorim MM; de Souza PR; Crovella S
Ann Hum Biol; 2016 May; 43(3):261-8. PubMed ID: 26079218
[TBL] [Abstract][Full Text] [Related]
30. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y
BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676
[TBL] [Abstract][Full Text] [Related]
31. Pathway analysis of cervical cancer genome-wide association study highlights the MHC region and pathways involved in response to infection.
Chen D; Enroth S; Ivansson E; Gyllensten U
Hum Mol Genet; 2014 Nov; 23(22):6047-60. PubMed ID: 24934695
[TBL] [Abstract][Full Text] [Related]
32. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
33. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J; Chow SN; Kitchener H; Teixeira JC; Hedrick J; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; De Carvalho NS; Germar MJ; Peters K; Mindel A; De Sutter P; Bosch FX; David MP; Descamps D; Struyf F; Dubin G;
Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
[TBL] [Abstract][Full Text] [Related]
34. Genetic susceptibility to cervical neoplasia.
Brown MA; Leo PJ
Papillomavirus Res; 2019 Jun; 7():132-134. PubMed ID: 30954690
[TBL] [Abstract][Full Text] [Related]
35. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
36. Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Ng SC; Wang PH; Lee YC; Lee CY; Yang SF; Shen HP; Hsiao YH
Int J Med Sci; 2019; 16(6):774-782. PubMed ID: 31337950
[TBL] [Abstract][Full Text] [Related]
37. Expression quantitative trait loci in long non-coding RNA PAX8-AS1 are associated with decreased risk of cervical cancer.
Han J; Zhou W; Jia M; Wen J; Jiang J; Shi J; Zhang K; Ma H; Liu J; Ren J; Dai M; Hu Z; Hang D; Li N; Shen H
Mol Genet Genomics; 2016 Aug; 291(4):1743-8. PubMed ID: 27225188
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract][Full Text] [Related]
39. The association of the immune response genes to human papillomavirus-related cervical disease in a Brazilian population.
Marangon AV; Guelsin GA; Visentainer JE; Borelli SD; Watanabe MA; Consolaro ME; Caleffi-Ferracioli KR; Rudnick CC; Sell AM
Biomed Res Int; 2013; 2013():146079. PubMed ID: 23936772
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
Safaeian M; Hildesheim A; Gonzalez P; Yu K; Porras C; Li Q; Rodriguez AC; Sherman ME; Schiffman M; Wacholder S; Burk R; Herrero R; Burdette L; Chanock SJ; Wang SS
PLoS One; 2012; 7(4):e33619. PubMed ID: 22496757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
